Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults.
Fraiman J, Erviti J, Jones M, Greenland S, Whelan P, Kaplan RM, Doshi P.
Fraiman J, et al. Among authors: doshi p.
Vaccine. 2022 Sep 22;40(40):5798-5805. doi: 10.1016/j.vaccine.2022.08.036. Epub 2022 Aug 31.
Vaccine. 2022.
PMID: 36055877
Free PMC article.
Clinical Trial.
INTRODUCTION: In 2020, prior to COVID-19 vaccine rollout, the Brighton Collaboration created a priority list, endorsed by the World Health Organization, of potential adverse events relevant to COVID-19 vaccines. We adapted the Brighton Collaboration li …
INTRODUCTION: In 2020, prior to COVID-19 vaccine rollout, the Brighton Collaboration created a priority list, endorsed by the …